About TheraCell
TheraCell is a Healthcare company based in Northridge (United States) founded in 2008, and was acquired by ISTO Biologics in April 2022. Allograft solutions for spinal surgery are provided by TheraCell. TheraCell has raised $1.42 million across 2 funding rounds from investors including ISTO Biologics. The company was acqui-hired. Its focus areas include HealthTech, Veterinary HealthTech, Biopharmaceuticals and Companion Animals. Its legal entity is TheraCell, Inc. Its competitors include Imbed Biosciences, Osteal Therapeutics and Cresilon; 3 of its 3 listed competitors have raised funding.
Company details
TheraCell was founded in 2008 and is based in Northridge, United States. Allograft solutions tailored for spinal surgery procedures are offered by the company. Specific products include the TheraFuze DBF Fiber Wrap, Fiber Anchor, and Fiber Bag. Operations focus on the medical device sector, with emphasis on procedure-specific innovations for orthopedic applications in spinal care.
- Headquarters Northridge, United States
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website theracellinc.com
- Social LinkedIn
- Acquired by ISTO Biologics (Apr 2022)
- Legal Name Theracell, Inc
- Total Equity Funding$1.42M (USD)
in 2 rounds
- Latest Funding Round$75K (USD), Seed
Mar 2015
- Investors
- Acquired byISTO Biologics
(Apr 2022)
Funding Insights of TheraCell
TheraCell has successfully raised a total of $1.42M across 2 strategic funding rounds. The most recent funding activity was a Seed round of $75 thousand completed in March 2015. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.42M
- Total Rounds 2
- Last Round Seed — $75,000
- First Round $1.34M
(Oct 2010)
All 2 funding rounds of TheraCell with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2015 | $75,000 | Seed | – | – | – |
| Oct 2010 | $1.34M | Seed | – | – | – |
1 investors in total: 1 institutional.
Investors in TheraCell
TheraCell has secured backing from 1 investor. Prominent investors backing the company include ISTO Biologics.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Developer of treatments for cartilage and bone problems | 1997 | istobiologics.com | St. Louis, United States |
Investor details for TheraCell
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Timeline of TheraCell
4 dated milestones of TheraCell across 14 years, from founding to its latest funding, stage changes and deals.
- Founded TheraCell is founded.
- Funding First funding round of $1.3M.
- Funding Latest funding round, Seed, of $75K.
- Exit Acquired by ISTO Biologics.
Competitors of TheraCell
TheraCell has 3 listed competitors in our database, 3 of them funded. They include Imbed Biosciences, Osteal Therapeutics and Cresilon.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| imbedbio.com | 2010 | Madison, United States | $22.7M | 35 | Nanotech-based wound care products are developed and provided. | |
| ostealtx.com | 2013 | San Clemente, United States | $110.8M | Developer of pharmaceuticals for musculoskeletal therapeutics to treat orthopedic infections | ||
| cresilon.com | 2010 | New York, United States | $106.67M | 73 | Developer of hemostatic products for wound care |
Detailed competitors of TheraCell
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Orthopedics
3 companies that operate in the same segment as TheraCell (Orthopedics) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Provider of high-frequency spinal cord stimulation implants | 2006 | Menlo Park, California, United States | USD 154.1 M | USD 353.08 M | 1,215 | |
Developer of therapies for the treatment of musculoskeletal disorders | 2007 | Woburn, Massachusetts, United States | USD 62 M | USD 85.55 M | 692 | |
Antibody-siRNA complexes are developed for cancer treatment. | 2012 | San Diego, California, United States | USD 142.54 M | USD 10.9 M | 391 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Theracell
Complete news archive for TheraCell
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about TheraCell
TheraCell was founded in 2008 and raised its 1st funding round 2 years after it was founded.
TheraCell is headquartered in Northridge, United States. It is registered at Northridge, California, United States.
TheraCell is a funded company, having raised a total of $1.42M across 2 funding rounds to date. The company's 1st funding round was a Seed of $1.34M, raised on Oct 2010.
TheraCell was founded in 2008 and is based in Northridge, United States. Allograft solutions tailored for spinal surgery procedures are offered by the company. Specific products include the TheraFuze DBF Fiber Wrap, Fiber Anchor, and Fiber Bag. Operations focus on the medical device sector, with emphasis on procedure-specific innovations for orthopedic applications in spinal care.
TheraCell's top competitors include Imbed Biosciences, Cresilon and Osteal Therapeutics.
TheraCell has 1 investor. Key investors include ISTO Biologics.
TheraCell operates through Theracell, Inc.
Yes. TheraCell was acquired by ISTO Biologics in April 2022.